GlassScriptPhysician profile
Austin G Hake
NPI 1003077389
$35,351.58
in general payments reported to CMS, 2019-2025
67 companies · $4,958 in 2025
The $4,958 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $848 · 2021: $5,927 · 2022: $14K · 2023: $4,548 · 2024: $4,035 · 2025: $4,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $964 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $875 · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,350.39 |
| Travel and Lodging | $963.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $875.00 |
| Education | $352.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17,732.04 | 2020-2025 | |
| Livanova USA, INC. | $2,344.84 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $980.11 | 2019-2025 | Rystiggo, Nayzilam, Briviact |
| Sk Life Science, INC. | $928.64 | 2020-2025 | Xcopri |
| Pfizer INC. | $825.66 | 2023-2025 | |
| Lilly USA, LLC | $814.34 | 2020-2025 | Kisunla, Emgality, Reyvow |
| Amgen INC. | $757.54 | 2019-2025 | Otezla, Repatha, Evenity |
| Teva Pharmaceuticals USA, INC. | $755.96 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Celgene Corporation | $701.35 | 2022-2025 | Zeposia |
| Neurocrine Biosciences, INC. | $667.67 | 2020-2025 | Ingrezza, Ongentys |
| Emd Serono, INC. | $667.15 | 2019-2025 | Mavenclad |
| Neurelis, INC. | $600.58 | 2021-2025 | Valtoco |
| Novartis Pharmaceuticals Corporation | $525.47 | 2019-2025 | |
| Argenx US, INC. | $524.75 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Acadia Pharmaceuticals INC | $520.79 | 2019-2025 | Nuplazid |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $445.46 | 2021-2025 | Wakix |
| Lundbeck LLC | $437.99 | 2023-2025 | Vyepti, Rexulti |
| Supernus Pharmaceuticals, INC. | $373.03 | 2021-2023 | |
| Eisai INC. | $358.18 | 2020-2025 | |
| Genentech USA, INC. | $314.96 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Biohaven Pharmaceutical Holding Company LTD. | $314.67 | 2022 | |
| Biogen, INC. | $306.17 | 2019-2025 | Tysabri, Vumerity, Qalsody |
| Jazz Pharmaceuticals INC. | $274.61 | 2020-2025 | |
| Allergan, INC. | $228.93 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $213.05 | 2021-2025 | Rexulti, Abilify Maintena |
| Genzyme Corporation | $212.20 | 2019-2023 | |
| Acorda Therapeutics, INC | $187.08 | 2019-2023 | Inbrija, Ampyra |
| Vanda Pharmaceuticals INC. | $179.19 | 2025 | Ponvory, Fanapt |
| E.R. Squibb & Sons, L.L.C. | $158.99 | 2021-2024 | Zeposia |
| Abbott Laboratories | $151.87 | 2019-2025 | Infinity |
| Novo Nordisk INC | $126.55 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Medtronic, INC. | $119.50 | 2021-2022 | |
| Tanabe Pharma America, INC. | $109.90 | 2020-2025 | Radicava |
| Catalyst Pharmaceuticals, INC. | $109.39 | 2021-2024 | Firdapse |
| Upsher-Smith Laboratories LLC | $101.31 | 2020-2021 | |
| Medtronic USA, INC. | $95.96 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $89.57 | 2020-2022 | |
| Boston Scientific Corporation | $87.48 | 2021-2024 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Adamas Pharmaceuticals, INC. | $80.92 | 2020-2021 | |
| Ge Healthcare | $80.12 | 2022-2024 | |
| Impel Pharmaceuticals INC. | $77.12 | 2023 | Trudhesa |
| Kyowa Kirin, INC. | $73.02 | 2021-2024 | Nourianz |
| Biohaven Pharmaceuticals, INC. | $69.05 | 2020-2021 | |
| Cycle Pharmaceuticals INC | $59.12 | 2024-2025 | Tascenso Odt, Bafiertam |
| Takeda Pharmaceuticals U.S.A., INC. | $49.38 | 2021-2025 | Hyqvia |
| Merz Pharmaceuticals, LLC | $43.83 | 2025 | Inbrija, Xeomin |
| Grifols USA, LLC | $43.78 | 2025 | Gamunex-C |
| Ipsen Biopharmaceuticals, INC | $42.87 | 2024-2025 | Dysport |
| Avion Pharmaceuticals | $37.80 | 2022 | |
| Exact Sciences Corporation | $35.75 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $35.43 | 2024 | Aptiom |
| Horizon Therapeutics Plc | $25.78 | 2021 | |
| Avanir Pharmaceuticals, INC. | $23.25 | 2019 | |
| Janssen Biotech, INC. | $22.91 | 2025 | |
| Almatica Pharma LLC | $21.13 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.44 | 2022 | |
| Amarin Pharma, INC. | $18.77 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.88 | 2022 | |
| Averitas Pharma INC. | $17.12 | 2025 | Qutenza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.64 | 2021 | |
| Mdd US Operations, LLC | $16.19 | 2022 | |
| Ani Pharmaceuticals, INC. | $16.17 | 2022 | |
| Csl Behring | $14.10 | 2024 | Hizentra |
| Adlon Therapeutics L.P. | $13.27 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.93 | 2022 | |
| Electromed, INC. | $12.70 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Hake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.